Qualia Life
98/100
This product looks safe
- Niacin: 125mg is 3.6× the Tolerable Upper Intake Level (35mg)
- Folate: 303mg is 303.0× the Tolerable Upper Intake Level (1.0mg)
- 50% of ingredients have research evidence
D
Label Compliance Grade
What the Evidence Says
AI-generated · Qwen 3.6 · methodologyThe profile features B-vitamins and Vitamin K2, which are supported by strong evidence for energy metabolism and bone health. However, the overall evidence coverage for this specific formulation is very limited at 0.5%. The ingredients maintain a high safety score, suggesting a low risk for most users.
AI-generated summary based on research evidence. Not medical advice.
Alerts
Safety Alerts
Niacin: 125mg is 3.6× the Tolerable Upper Intake Level (35mg)
Folate: 303mg is 303.0× the Tolerable Upper Intake Level (1.0mg)
Label
Product Label
Details
Label Data
8 Vegetarian Capsule(s)
Serving Size
20
Servings
Other Combinations
Product Type
50%
Evidence Coverage
Ingredients
Supplement Facts — Evidence Check
50 mcg
(42% DV)
Within RDA (0.4× RDA)
275 studies (A:9, B:175)
25 mg
(2085% DV)
20.8× RDA — above typical dose
76 studies (A:0, B:33)
2 mg
(154% DV)
1.5× RDA — within safe limits
13 studies (A:0, B:1)
125 mg
(781% DV)
Exceeds UL by 3.6× (UL: 35 mg)
196 studies (A:5, B:63)
1.3 mg
(76% DV)
Within RDA (1.0× RDA)
114 studies (A:3, B:35)
303 mcg DFE
(76% DV)
Exceeds UL by 303.0× (UL: 1.0 mg)
226 studies (A:10, B:105)
200 mcg
(8330% DV)
83.3× RDA — above typical dose
139 studies (A:1, B:44)
30 mcg
(100% DV)
Within RDA (1.0× RDA)
27 studies (A:0, B:11)
5 mg
(100% DV)
Within RDA (1.0× RDA)
2 studies — no high-quality reviews
48 mg
(11% DV)
Within RDA (0.1× RDA)
316 studies (A:8, B:159)
1000 mg
Market median: 5.0mg (298 products)
705 studies (A:5, B:123)
Market median: 4002.0mg (1 products)
21 studies (A:0, B:2)
Glycine
344 mg
Rosmarinus officinalis leaf extract
300 mg
Cocoa seed extract
300 mg
Cinnulin PF Cinnamomum burmannii bark extract
250 mg
250 mg
Market median: 500.0mg (861 products)
61 studies (A:4, B:13)
BioVin French Red Grapes extract
200 mg
200 mg
Market median: 550.0mg (217 products)
29 studies (A:0, B:5)
elevATP
150 mg
125 mg
Market median: 496.0mg (192 products)
20 studies — no high-quality reviews
Market median: 450.0mg (502 products)
28 studies (A:0, B:8)
Gynostemma pentaphyllum whole herb extract
100 mg
Sirtmax Kaempferia parviflora root extract
100 mg
100 mg
Market median: 4002.0mg (1 products)
21 studies (A:0, B:2)
N-Acetyl-L-Cysteine
100 mg
100 mg
Market median: 500.0mg (70 products)
65 mg
Market median: 100.0mg (283 products)
144 studies (A:1, B:64)
Sophorae japonica L. flower extract
50 mg
Citrus sinensis L. fruit extract
50 mg
Strawberry seed extract
40 mg
Citrus grandis fruit extract
20 mg
Market median: 4002.0mg (1 products)
21 studies (A:0, B:2)
Ceratonia siliqua pod extract
5 mg
Other Ingredients
Hypromellose
organic Rice concentrate
organic Rice extract Blend
Silicon Dioxide
Calcium Carbonate
Claims
Label Claims — Verification
Unverified
Structure/Function
Info
Product Information
Formulation Notes
Optimized aging Energy Sleep Cognition
Cinnulin PF BioVin Advanced with Red Wine extract, with 5% Reservatrol elevATP Strength, Power, Performance Sensoril
Manufactured in a cGMP compliant facility
Additional Information
28 day supply
Metadata
Product Details
Research
Research Evidence
332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
A
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
A
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
A
Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
A
Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
A
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
A
Antiplatelet agents and anticoagulants for hypertension
A
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
A
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Compare
Similar Products
Vitamin D Synergy with Vitamin K1
Designs for Health · Capsule
100
Vitamin D Synergy with Vitamin K1
Designs for Health · Capsule
100
Natural Vitamin K2 45 mcg
Doctor's Best · Capsule
100
K 100 mcg
Thompson · Capsule
100
Vitamin K2 300 mcg MK-7
Innerzyme · Capsule
100
This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.